Clinical Trial Update: Transposon-manipulated Allogeneic CARCIK-CD19 Cells in Pediatric and Adult Patients With r/r ALL Post HSCT [Phase 1, Phase 2]

View source ↗

Summary

Phase 1/2 trial evaluating transposon-manipulated allogeneic CARCIK-CD19 cells in pediatric and adult patients with relapsed/refractory acute lymphoblastic leuk…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Acute Lymphoblastic Leukemia in Relapse

Drugs mentioned

• CARCIK-CD19 cells (transposon-manipulated allogeneic)

Snippet

Sponsor: Fondazione Matilde Tettamanti Menotti De Marchi Onlus | Conditions: Acute Lymphoblastic Leukemia, in Relapse | Phase 1, Phase 2 | Status: COMPLETED